Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral transmucosal fentanyl citrate analgesia in prehospital trauma care: a retrospective observational cohort study focusing on age and gender differences.

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

Stability of emergency medications during extreme cold: a controlled environmental study.

Scandinavian journal of trauma, resuscitation and emergency medicine·2025
Same author

[Unexpected tracheal lesion after intubation-Call for discussion].

Die Anaesthesiologie·2025
Same author

[Just culture as a chance for the future for hospitals].

Die Anaesthesiologie·2025
Same author

Droplet Formation in Drugs During Extreme Temperature Conditions in the Emergency Medical Service, a Problem?

Air medical journal·2025
Same author

Emergency critical care - life-saving critical care before ICU admission: A consensus statement of a Group of European Experts.

Journal of critical care·2025

Related Experiment Video

Updated: Jul 19, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Vasopressin in shock states.

Hans-Ulrich Strohmenger1, Anette Krismer, Volker Wenzel

  • 1Department of Anaesthesiology and Critical Care Medicine, Leopold-Franzens-University, Innsbruck, Austria. hans.strohmenger@iubk.ac.at

Current Opinion in Anaesthesiology
|October 6, 2006
PubMed
Summary

Arginine vasopressin shows promise in treating shock and cardiac arrest by counteracting low vasopressin levels. Further research is needed, but current evidence suggests it

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jul 19, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Low endogenous vasopressin levels are linked to poor outcomes in shock and cardiac arrest.
  • Pathologic vasodilation and inadequate organ perfusion contribute to mortality.

Purpose of the Study:

  • To review recent literature on arginine vasopressin's role as a vasoconstrictor in shock states.
  • To evaluate vasopressin's efficacy in systemic vasodilation, hypovolemia, and cardiac arrest.

Main Methods:

  • Review of retrospective investigations and experimental data.
  • Analysis of clinical experience in cardiopulmonary resuscitation.
  • Consideration of ongoing European multicenter studies.

Main Results:

  • Vasopressin (2-6 U/h) may reverse catecholamine-resistant vasodilatory shock.
  • Animal studies show improved circulation and neurological outcomes during CPR.
  • Clinical data suggests vasopressin is equipotent to epinephrine in in-hospital CPR and improves survival in out-of-hospital ventricular fibrillation.

Conclusions:

  • Vasopressin administration is a promising therapeutic approach for shock and cardiac arrest.
  • Further prospective randomized controlled trials are warranted to confirm efficacy and optimal dosing.